Preferred therapies for neovascular age-related macular degeneration.

Lally, David R; Gerstenblith, Adam T; Regillo, Carl D

Lally, David R; Gerstenblith, Adam T; Regillo, Carl D.

Affiliation

Lally DR; Retina Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.

Curr Opin Ophthalmol ; 23(3): 182-8, 2012 May.

Article in En | MEDLINE | ID: mdl-22450218

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Wet Macular Degeneration/drug therapy; Antibodies, Monoclonal, Humanized/therapeutic use; Bevacizumab; Humans; Ranibizumab; Receptors, Vascular Endothelial Growth Factor/therapeutic use; Recombinant Fusion Proteins/therapeutic use; Vascular Endothelial Growth Factor A/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Angiogenesis Inhibitors / Wet Macular Degeneration Limits: Humans Language: En Journal: Curr Opin Ophthalmol Journal subject: OFTALMOLOGIA Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google